Innovative People


Alexei von Delwig

Alexei von Delwig
I have developed a new technology to screen blood T cells for responsiveness to certain post-translationally modified (Citrullinated) joint antigens. This invention will be the basis for diagnostic test and immunotherapy development in the area of rheumaatology

Sign-up For Our Newsletter

Our free Innovation Newsletter is sent to 40,000+ subscribers every week. Stay informed and subscribe now to receive the next issue!

I'd like to Subscribe